Nextstellis® (drospirenone/estetrol) – New drug approval
April 16, 2021 - Mayne Pharma and Mithra Pharmaceuticals announced the FDA approval of Nextstellis (drospirenone/estetrol), for use by females of reproductive potential to prevent pregnancy.
Download PDF
